US Patent Issued to Shanghai Hansoh Biomedical, Jiangsu Hansoh Pharmaceutical Group on Oct. 6 for "Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,166, issued on Oct. 6, was assigned to Shanghai Hansoh Biomedical Co. Ltd. (Shanghai) and Jiangsu Hansoh Pharmaceutical Group Co. Ltd. (Lianyungang, China).

"Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof" was invented by Jinyao Chen (Shanghai) and Yuanyuan Li (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a salt containing a piperazine polycyclic derivative, a crystal form thereof, a preparation method therefor, and the use thereof. In particular, the present invention relates to a salt containing a compound of general formula (I) and a stereoisomer thereof,...